In this study, we combined the beneficial effects of MSCs and SIRT1 on the treatment of organ fibrosis to establish the SIRT1-modified hUCMSCs and investigated its therapeutic potential for the treatment of peritoneal fibrosis. The gene discussed is SIRT1; the disease is Peritoneal Fibrosis.